When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTEC - Intec Pharma commences early-stage study of cannabinoid Accordion Pill
Intec Pharma Ltd.
Dosing is underway in a Phase 1 clinical trial evaluating Intec Pharma's (NASDAQ:NTEC) Accordion Pill containing tetrahydrocannabinol (THC), AP-THC. The study will assess the safety, tolerability and pharmacokinetics in 18 healthy volunteers.
More news on: Intec Pharma, Healthcare stocks news,